$8.03 Billion is the total value of HHLR ADVISORS, LTD.'s 54 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | BEIGENE LTDsponsored adr | $907,082,000 | +35.4% | 5,472,259 | 0.0% | 11.30% | +22.7% | |
| ESGR | ENSTAR GROUP LIMITED | $361,558,000 | +8.9% | 1,747,840 | 0.0% | 4.50% | -1.3% | |
| CBPO | CHINA BIOLOGIC PRODS HLDGS I | $320,185,000 | +1.7% | 2,751,200 | 0.0% | 3.99% | -7.9% | |
| BBIO | BRIDGEBIO PHARMA INC | $153,824,000 | +63.3% | 4,388,690 | 0.0% | 1.92% | +48.0% | |
| APLS | APELLIS PHARMACEUTICALS INC | $143,249,000 | +27.1% | 4,678,289 | 0.0% | 1.78% | +15.2% | |
| MDLZ | MONDELEZ INTL INCcl a | $140,265,000 | -0.4% | 2,546,564 | 0.0% | 1.75% | -9.8% | |
| GOSS | GOSSAMER BIO INC | $92,397,000 | -6.9% | 5,911,541 | 0.0% | 1.15% | -15.6% | |
| SNAP | SNAP INCcl a | $72,928,000 | +3.4% | 4,465,885 | 0.0% | 0.91% | -6.3% | |
| MYOK | MYOKARDIA INC | $71,135,000 | +39.8% | 975,987 | 0.0% | 0.89% | +26.6% | |
| NXTC | NEXTCURE INC | $59,348,000 | +82.6% | 1,053,570 | 0.0% | 0.74% | +65.3% | |
| BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $35,195,000 | -8.7% | 3,985,797 | 0.0% | 0.44% | -17.4% | |
| ARVN | ARVINAS INC | $35,145,000 | +90.7% | 855,308 | 0.0% | 0.44% | +73.1% | |
| GMAB | GENMAB A Ssponsored ads | $33,495,000 | +10.2% | 1,500,000 | 0.0% | 0.42% | -0.2% | |
| ZLAB | ZAI LAB LTDadr | $33,189,000 | +28.6% | 798,001 | 0.0% | 0.41% | +16.3% | |
| GTHX | G1 THERAPEUTICS INC | $25,093,000 | +16.0% | 949,431 | 0.0% | 0.31% | +5.4% | |
| MOGU | MOGU INCspon ads | $23,818,000 | -9.3% | 10,446,970 | 0.0% | 0.30% | -17.7% | |
| RGNX | REGENXBIO INC | $18,682,000 | +15.1% | 456,000 | 0.0% | 0.23% | +4.5% | |
| IGMS | IGM BIOSCIENCES INC | $13,356,000 | +115.0% | 350,000 | 0.0% | 0.17% | +95.3% | |
| HOOK | HOOKIPA PHARMA INC | $11,536,000 | +63.1% | 943,254 | 0.0% | 0.14% | +48.5% | |
| EIDX | EIDOS THERAPEUTICS INC | $10,250,000 | +59.6% | 178,600 | 0.0% | 0.13% | +45.5% | |
| SOHU | SOHU COM LTDsponsored ads | $8,967,000 | +10.0% | 802,034 | 0.0% | 0.11% | 0.0% | |
| CJJD | CHINA JO-JO DRUGSTORES INC | $8,809,000 | +50.4% | 4,840,000 | 0.0% | 0.11% | +35.8% | |
| RCUS | ARCUS BIOSCIENCES INC | $7,748,000 | +11.0% | 767,128 | 0.0% | 0.10% | +1.0% | |
| TXG | 10X GENOMICS INC | $5,719,000 | +51.3% | 75,000 | 0.0% | 0.07% | +36.5% | |
| TCRR | TCR2 THERAPEUTICS INC | $4,611,000 | -5.0% | 322,903 | 0.0% | 0.06% | -14.9% | |
| CBMG | CELLULAR BIOMEDICINE GROUP I | $3,820,000 | +9.3% | 235,214 | 0.0% | 0.05% | 0.0% | |
| CIH | CHINA INDEX HLDGS LTDspnsrd ads a | $1,092,000 | -6.7% | 300,000 | 0.0% | 0.01% | -12.5% | |
| NEW | PUXIN LTDads | $1,034,000 | +2.9% | 126,145 | 0.0% | 0.01% | -7.1% | |
| SFUN | FANG HLDGS LTDadr new | $858,000 | +28.8% | 300,000 | 0.0% | 0.01% | +22.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.